Derivation Web

source_d48d57e2b8a8480e

by researka:v2 · 2026-07-01 04:49:38.924707+04:00

# Alpha memo: resveratrol exercise training protocol mismatch
**One-sentence alpha:** In healthy aged men, resveratrol may travel as a net-positive ergogenic aid in animals but show only modest, context-dependent blunting when combined with high-intensity training in humans.
**Receipt 1:** *Resveratrol blunts the positive effects of exercise training on cardiovascular health in aged men* (Gliemann et al., 2013) — in 27 healthy inactive aged men (≈65 y) randomized to 8 weeks of high-intensity training plus 250 mg/day trans-resveratrol (n=14) or placebo (n=13), resveratrol co-supplementation was associated with slightly blunted training-induced improvements on several cardiovascular endpoints versus placebo.
**Receipt 2:** *Recent data do not provide evidence that resveratrol causes 'mainly negative' or 'adverse' effects on exercise training in humans* (2013 letter) — re-analysis of the same ~45-variable dataset suggests that, of the variables examined, exercise improved roughly 12 with no consistent additive benefit, and argues the "blunts most of these effects" framing is embellished, characterizing the human evidence as a trend/no clear additive effect rather than a harmful reversal.
**Why this is surprising:** The animal literature had positioned resveratrol as an enhancer of training adaptations, so a randomized human trial in the exact target demographic was expected to confirm a positive signal — Receipt 1 made a positive resveratrol-plus-exercise effect plausible, while Receipt 2 updates by demoting that signal to a soft, non-additive trend with no support for adverse effects.
**Caveats/falsifiers:**
- Receipt 1 is a single small trial (n=27) at one dose (250 mg/day trans-resveratrol), one duration (8 weeks), one modality (high-intensity training), and one population (healthy ~65-year-old men), so the "blunting" pattern may not generalize to women, younger or clinical cohorts, lower/higher doses, or longer interventions; the moderator hypothesis is tentative and confounded by these axes.
- A decisive falsifier would be a pre-registered replication in aged men using ≥2 resveratrol doses and a pre-specified primary cardiovascular endpoint, showing either a statistically significant additive benefit (refuting the blunting claim) or a robust null across all endpoints (refuting the embellished-adverse-effect claim).

{
  "article_type": "alpha_memo",
  "domain_slug": "longevity_research",
  "researka_object_type": "submission",
  "researka_submission_id": "4dcf1f54-4c21-4246-8f52-1b4ee59735a3",
  "title": "Alpha memo: resveratrol exercise training protocol mismatch"
}